| Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy K Kärre, HG Ljunggren, G Piontek, R Kiessling Nature 319 (6055), 675-678, 1986 | 2831 | 1986 |
| „Natural” ︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype R Kiessling, E Klein, H Wigzell European journal of immunology 5 (2), 112-117, 1975 | 2620 | 1975 |
| „Natural” ︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell R Kiessling, E Klein, H Pross, H Wigzell European journal of immunology 5 (2), 117-121, 1975 | 1580 | 1975 |
| The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations B Agerberth, J Charo, J Werr, B Olsson, F Idali, L Lindbom, R Kiessling, ... Blood, The Journal of the American Society of Hematology 96 (9), 3086-3093, 2000 | 1008 | 2000 |
| Heat-shock proteins as activators of the innate immune system RPA Wallin, A Lundqvist, SH Moré, A von Bonin, R Kiessling, ... Trends in immunology 23 (3), 130-135, 2002 | 785 | 2002 |
| Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts R Kiessling, PS Hochman, O Haller, GM Shearer, H Wigzell, G Cudkowicz European journal of immunology 7 (9), 655-663, 1977 | 594 | 1977 |
| Regulatory T cells in cancer D Mougiakakos, A Choudhury, A Lladser, R Kiessling, CC Johansson Advances in cancer research 107, 57-117, 2010 | 593 | 2010 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 547 | 2014 |
| Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign I Poschke, D Mougiakakos, J Hansson, GV Masucci, R Kiessling Cancer research 70 (11), 4335-4345, 2010 | 485 | 2010 |
| An analysis of the murine NK cell as to structure, function and biological relevance. R Kiessling, H Wigzell | 457 | 1979 |
| Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated … K Kono, F Salazar‐Onfray, M Petersson, J Hansson, G Masucci, ... European journal of immunology 26 (6), 1308-1313, 1996 | 424 | 1996 |
| Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression. M Matsuda, F Salazar, M Petersson, G Masucci, J Hansson, P Pisa, ... The Journal of experimental medicine 180 (6), 2371-2376, 1994 | 417 | 1994 |
| Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma H Nakagomi, M Petersson, I Magnusson, C Juhlin, M Matsuda, ... Cancer research 53 (23), 5610-5612, 1993 | 417 | 1993 |
| Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo O Haller, M Hansson, R Kiessling, H Wigzell Nature 270 (5638), 609-611, 1977 | 362 | 1977 |
| Tumor-induced immune dysfunction R Kiessling, K Wasserman, S Horiguchi, K Kono, J Sjöberg, P Pisa, ... Cancer immunology, immunotherapy 48, 353-362, 1999 | 331 | 1999 |
| Circulating heat shock protein 60 is associated with early cardiovascular disease AG Pockley, R Wu, C Lemne, R Kiessling, U de Faire, J Frostegård Hypertension 36 (2), 303-307, 2000 | 323 | 2000 |
| Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. P Pisa, E Halapi, EK Pisa, E Gerdin, C Hising, A Bucht, B Gerdin, ... Proceedings of the National Academy of Sciences 89 (16), 7708-7712, 1992 | 310 | 1992 |
| DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ... Cancer research 67 (3), 1317-1325, 2007 | 309 | 2007 |
| Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity Y Mao, D Sarhan, A Steven, B Seliger, R Kiessling, A Lundqvist Clinical cancer research 20 (15), 4096-4106, 2014 | 295 | 2014 |
| Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ... The Journal of Immunology 183 (8), 4921-4930, 2009 | 295 | 2009 |
